RISPERIDONE-1 MG. MOUTH DISSOLVING

RISPERIDONE-1 MG. MOUTH DISSOLVING Specification

Form
Tablet

Shelf Life
36 Months

Grade
Pharmaceutical Grade

Function
Mental, Mood Disorders

Purity
89%

Color
White

Storage Instructions
Cool & Dry place

RISPERIDONE-1 MG. MOUTH DISSOLVING Trade Information

Minimum Order Quantity
10 Strips

Supply Ability
5000 Strips Per Month

Delivery Time
Days

Main Domestic Market
All India

About RISPERIDONE-1 MG. MOUTH DISSOLVING

Better than typical antipsychotics

Allows more refractory time between episodes than typical antipsychotics We conclude that there is a very high rate of discontinuation of the initial antipsychotic medications for various reasons with risperidone having an overall longer time to discontinuation compared with firstgeneration antipsychotic medications

Liew A et al J Psychopharmacol 2010 Mar

Approved by US FDA in adolescent schizophrenia

Risperidone has been approved by the Food and Drug Administration for the treatment of schizophrenia in the adolescent population

Madaan VDrugs Today Barc 2009 Jan4515562

Indicated in

Acute and chronic schizophrenia

Bipolar disorders

Tourettes disorder

Behaviour disorder in dementia

Disruptive behaviour disorders in children

Tell us about your requirement